Utah State University Report Highlights Kratom's Regulatory Challenges and Merchant Responsibilities

Utah State University Report Highlights Kratom's Regulatory Challenges and Merchant Responsibilities

Salt Lake City, UT – A recent report from Utah State University (USU) titled "The Truth About Kratom: What You Should Know," published on February 23, 2026, sheds light on the growing use of kratom in the United States, its unregulated status, and the associated risks. The article, authored by Ashley Yaugher, underscores the critical need for greater understanding among consumers and stricter adherence to responsible practices by merchants, particularly in light of new regulations set to take effect in Utah in May 2026.

What Happened: USU Details Kratom's Complex Landscape

The USU report outlines kratom (Mitragyna speciosa) as a tropical tree traditionally used in Southeast Asia for mild energy boosts and opioid-like pain relief. However, its increased availability in the U.S. in various forms—capsules, powders, and liquid extracts—has led to products being "inappropriately marketed as health supplements" without sufficient data to back such claims. A central point of concern is that kratom is not regulated by the FDA, leading to significant variability in product composition and potential safety issues. The article highlights possible toxicities, including increased liver toxicity, seizures, substance use disorder, and even death, especially when combined with other substances. Common adverse effects like cravings, irritability, anxiety, and withdrawal symptoms are also noted. Crucially, the report mentions that these issues have prompted updated Utah bills and regulations, which will become effective in May 2026.

Why It Matters to Kratom Merchants and Consumers

For consumers, the USU report serves as a vital warning about the potential dangers of unregulated kratom products. The lack of standardized testing means that users may not fully understand what they are consuming or the unpredictable levels of active alkaloids present in synthetic or highly concentrated extracts. This emphasizes the need for informed decisions and caution when purchasing kratom.

For kratom merchants, the article underscores the heightened scrutiny on marketing practices and product claims. The explicit mention of "repercussions for marketing and labeling that could attract minors" and false promotion as a "safe dietary supplement" signals a clear regulatory focus on transparency and ethical advertising. This academic publication, combined with legislative action in Utah, indicates a growing trend towards tighter oversight that could influence regulations in other states.

Compliance Implications for the Industry

The most direct compliance implication stems from Utah's upcoming bills and regulations, effective May 2026. Merchants operating in Utah, or those selling to Utah consumers, must immediately familiarize themselves with these new requirements to ensure full compliance. More broadly, the report reinforces that the absence of federal FDA regulation places kratom in a "high-risk" category for payment processors and regulators alike. This environment necessitates proactive compliance efforts to avoid legal challenges, product seizures, or payment processing account terminations. The criticism of misleading marketing also implies a need for merchants to review all product descriptions and promotional materials to ensure they do not make unsubstantiated health claims or appeal to minors.

What High-Risk Merchants Need to Know: COAs, Lab Testing, and Regulatory Compliance

For high-risk kratom merchants, robust quality control and transparency are no longer optional—they are essential for business continuity and legal protection. The USU report’s concerns about "widely varying chemical composition" and "little or no safety testing" in commercial products directly point to the necessity of comprehensive, third-party lab testing.

Merchants must provide easily accessible Certificates of Analysis (COAs) for every batch of product, detailing:

• Alkaloid Content: Verification of key alkaloids like mitragynine and 7-hydroxymitragynine to ensure consistent potency and prevent misrepresentation.
• Purity: Testing for contaminants such as heavy metals, pesticides, and microbial impurities.
• Absence of Adulterants: Confirmation that products are free from synthetic compounds or other harmful additives.

Beyond lab testing, regulatory compliance demands continuous vigilance. High-risk merchants must:

• Stay Informed: Actively monitor legislative developments at both state and local levels, particularly in states like Utah leading regulatory efforts.
• Responsible Marketing: Strictly avoid making medical claims, dietary supplement claims, or any unsubstantiated health benefits. Ensure all marketing is age-appropriate and factual.
• Age Verification: Implement stringent age verification processes for all sales to prevent access by minors.

By prioritizing transparency through rigorous lab testing and adhering to evolving regulatory landscapes, kratom merchants can mitigate risks, build consumer trust, and navigate the complex payment compliance environment more effectively.